Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic - PubMed (original) (raw)
Review
Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic
Swati Kumar et al. Clin Microbiol Rev. 2012 Apr.
Abstract
The menu of diagnostic tools that can be utilized to establish a diagnosis of influenza is extensive and includes classic virology techniques as well as new and emerging methods. This review of how the various existing diagnostic methods have been utilized, first in the context of a rapidly evolving outbreak of novel influenza virus and then during the different subsequent phases and waves of the pandemic, demonstrates the unique roles, advantages, and limitations of each of these methods. Rapid antigen tests were used extensively throughout the pandemic. Recognition of the low negative predictive values of these tests is important. Private laboratories with preexisting expertise, infrastructure, and resources for rapid development, validation, and implementation of laboratory-developed assays played an unprecedented role in helping to meet the diagnostic demands during the pandemic. FDA-cleared assays remain an important element of the diagnostic armamentarium during a pandemic, and a process must be developed with the FDA to allow manufacturers to modify these assays for detection of novel strains in a timely fashion. The need and role for subtyping of influenza viruses and antiviral susceptibility testing will likely depend on qualitative (circulating subtypes and their resistance patterns) and quantitative (relative prevalence) characterization of influenza viruses circulating during future epidemics and pandemics.
Figures
Similar articles
- Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response.
Jernigan DB, Lindstrom SL, Johnson JR, Miller JD, Hoelscher M, Humes R, Shively R, Brammer L, Burke SA, Villanueva JM, Balish A, Uyeki T, Mustaquim D, Bishop A, Handsfield JH, Astles R, Xu X, Klimov AI, Cox NJ, Shaw MW. Jernigan DB, et al. Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S36-43. doi: 10.1093/cid/ciq020. Clin Infect Dis. 2011. PMID: 21342897 - Role of rapid immunochromatographic antigen testing in diagnosis of influenza A virus 2009 H1N1 infection.
Welch DF, Ginocchio CC. Welch DF, et al. J Clin Microbiol. 2010 Jan;48(1):22-5. doi: 10.1128/JCM.02268-09. Epub 2009 Dec 9. J Clin Microbiol. 2010. PMID: 20007399 Free PMC article. - The evolving threat of influenza viruses of animal origin and the challenges in developing appropriate diagnostics.
Mak PW, Jayawardena S, Poon LL. Mak PW, et al. Clin Chem. 2012 Nov;58(11):1527-33. doi: 10.1373/clinchem.2012.182626. Epub 2012 Sep 11. Clin Chem. 2012. PMID: 22968105 Review. - Evaluation of a new rapid test for the detection of influenza A and B viruses and pandemic (H1N1) 2009 virus subtyping in respiratory samples.
Lévêque N, Talmud D, Renois F, Barbe C, Andréoletti L. Lévêque N, et al. J Med Microbiol. 2011 Sep;60(Pt 9):1403-1404. doi: 10.1099/jmm.0.030585-0. Epub 2011 Apr 1. J Med Microbiol. 2011. PMID: 21459910 No abstract available. - Detection methods for influenza A H1N1 virus with special reference to biosensors: a review.
R R, Dalal A, Mohan H, Prasad M, Pundir CS. R R, et al. Biosci Rep. 2020 Feb 28;40(2):BSR20193852. doi: 10.1042/BSR20193852. Biosci Rep. 2020. PMID: 32016385 Free PMC article. Review.
Cited by
- Respiratory viral testing: new frontiers in diagnostics and implications for antimicrobial stewardship.
McCulloh RJ, Koster M, Chapin K. McCulloh RJ, et al. Virulence. 2013 Jan 1;4(1):1-2. doi: 10.4161/viru.22788. Virulence. 2013. PMID: 23314568 Free PMC article. No abstract available. - Can newly developed, rapid immunochromatographic antigen detection tests be reliably used for the laboratory diagnosis of influenza virus infections?
Dunn JJ, Ginocchio CC. Dunn JJ, et al. J Clin Microbiol. 2015 Jun;53(6):1790-6. doi: 10.1128/JCM.02739-14. Epub 2014 Oct 1. J Clin Microbiol. 2015. PMID: 25274999 Free PMC article. - Effect of Culture-Independent Diagnostic Tests on Future Emerging Infections Program Surveillance.
Langley G, Besser J, Iwamoto M, Lessa FC, Cronquist A, Skoff TH, Chaves S, Boxrud D, Pinner RW, Harrison LH. Langley G, et al. Emerg Infect Dis. 2015 Sep;21(9):1582-8. doi: 10.3201/eid2109.150570. Emerg Infect Dis. 2015. PMID: 26291736 Free PMC article. - How recent advances in molecular tests could impact the diagnosis of pneumonia.
Murdoch DR. Murdoch DR. Expert Rev Mol Diagn. 2016;16(5):533-40. doi: 10.1586/14737159.2016.1156536. Epub 2016 Mar 7. Expert Rev Mol Diagn. 2016. PMID: 26891612 Free PMC article. Review. - Role of molecular diagnostics in the management of infectious disease emergencies.
Krishna NK, Cunnion KM. Krishna NK, et al. Med Clin North Am. 2012 Nov;96(6):1067-78. doi: 10.1016/j.mcna.2012.08.005. Epub 2012 Sep 27. Med Clin North Am. 2012. PMID: 23102477 Free PMC article. Review.
References
- Adamson WE, et al. 2011. Population exposure to a novel influenza A virus over three waves of infection. J. Clin. Virol. 52: 300–303 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical